316 related articles for article (PubMed ID: 36442770)
21. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
[TBL] [Abstract][Full Text] [Related]
22. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
[TBL] [Abstract][Full Text] [Related]
23. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature.
Wirtschafter E; VanBeek C; Linhares Y
Exp Hematol Oncol; 2018; 7():14. PubMed ID: 29977661
[TBL] [Abstract][Full Text] [Related]
25. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.
Epperla N; Li A; Logan B; Fretham C; Chhabra S; Aljurf M; Chee L; Copelan E; Freytes CO; Hematti P; Lazarus HM; Litzow M; Nishihori T; Olsson RF; Prestidge T; Saber W; Wirk B; Yared JA; Loren A; Pasquini M
Br J Haematol; 2020 Jun; 189(6):1171-1181. PubMed ID: 32124435
[TBL] [Abstract][Full Text] [Related]
26. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
[TBL] [Abstract][Full Text] [Related]
28. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
29. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
[TBL] [Abstract][Full Text] [Related]
31. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange.
Xu Y; Wei Y; Wang L; Lu N; Wu Y; Dou L; Liu D; Li M; Gao C
Ann Transplant; 2023 Jun; 28():e939890. PubMed ID: 37337423
[TBL] [Abstract][Full Text] [Related]
32. Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.
Van Benschoten V; Roy C; Gupta R; Ouellette L; Hingorani S; Li A
Transplant Cell Ther; 2022 May; 28(5):266.e1-266.e8. PubMed ID: 35042011
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
[TBL] [Abstract][Full Text] [Related]
34. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
Jodele S; Sabulski A
Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Successful Treatment With Anti-C5 Monoclonal Antibody in a Japanese Adolescent Who Developed Thrombotic Microangiopathy After Autologous Bone Marrow Transplantation for Malignant Lymphoma.
Shimizu S; Morohashi T; Kanezawa K; Yagasaki H; Takahashi S; Morioka I
Front Pediatr; 2022; 10():908183. PubMed ID: 35859949
[TBL] [Abstract][Full Text] [Related]
36. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B; Krishnamurti L; Williams KM; Chonat S
Blood Adv; 2023 May; 7(9):1784-1795. PubMed ID: 36075028
[TBL] [Abstract][Full Text] [Related]
37. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
Laskin BL; Goebel J; Davies SM; Khoury JC; Bleesing JJ; Mehta PA; Filipovich AH; Paff ZN; Lawrence JM; Yin HJ; Pinkard SL; Jodele S
Bone Marrow Transplant; 2011 May; 46(5):682-9. PubMed ID: 20697372
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
Tolbert VP; Dvorak CC; Golden C; Vissa M; El-Haj N; Perwad F; Matthay KK; Vo KT
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2031-2039. PubMed ID: 31199983
[TBL] [Abstract][Full Text] [Related]
39. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Benítez Carabante MI; Bueno D; Alonso García L; López Torija I; Marsal J; Fernandez Navarro JM; Uria Oficialdegui ML; Panesso M; Molina B; Beléndez Bieler C; Palomo P; Pérez Martínez A; Diaz-de-Heredia C
Transplant Cell Ther; 2024 Jun; 30(6):601.e1-601.e13. PubMed ID: 38521410
[TBL] [Abstract][Full Text] [Related]
40. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management.
Dvorak CC; Higham C; Shimano KA
Front Pediatr; 2019; 7():133. PubMed ID: 31024873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]